Full Text View
Tabular View
No Study Results Posted
Related Studies
Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension
This study is not yet open for participant recruitment.
Study NCT00709137   Information provided by VA Salt Lake City Health Care System
First Received: July 1, 2008   Last Updated: July 2, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Resistant Hypertension
Additional conditions recognized in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
spironolactone
amiloride
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sodium Channel Blockers
Therapeutic Uses
Sponsors listed in this trial
VA Salt Lake City Health Care System


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services